Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV)

✍ Scribed by John DeVincenzo; Jeffrey E. Cehelsky; Rene Alvarez; Sayda Elbashir; Jens Harborth; Iva Toudjarska; Lubomir Nechev; Veeravagu Murugaiah; Andre Van Vliet; Akshay K. Vaishnaw; Rachel Meyers

• Book ID: 113457649
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 488 KB
• Volume: 77
• Category: Article
• ISSN: 0166-3542
• DOI: 10.1016/j.antiviral.2007.11.009